6 May 2022
Ludwig Oxford’s Dr Romuald Binet will investigate tissue-specific regulation of the DNA damage response in melanoma.
24 March 2022
Professor Yang Shi has been elected Fellow of the Academy of the American Association for Cancer Research (AACR), class of 2022.
2 March 2022
The Pearl clinical study will recruit 3000 patients with high-risk conditions for liver cancer with the aim of detecting liver cancer earlier as part of the Cancer Research UK-funded DeLIVER programme led by Ludwig adjunct Professor Ellie Barnes.
25 February 2022
Research by Professor Yang Shi and colleagues suggests that METTL3-mediated RNA methylation promotes productive transcription.
17 February 2022
A project aimed at tackling heart failure led by Associate Professor Sarah De Val is to be funded by the 2022 TCS London Marathon with the British Heart Foundation as its Charity of the Year.
18 January 2022
A novel immunotherapeutic called VTP-600, based on Ludwig Oxford’s Benoit Van den Eynde’s preclinical research, is being tested in patients for the first time.
25 November 2021
A study from Professor Colin Goding’s group finds an unexpected mechanism controlling growth vs senescence in cancer.
11 November 2021
Interactions between transcription factors and the chromatin environment provide barriers controlling cell differentiation, according to research by Professor Yang Shi and colleagues.
19 October 2021
Dr Tammie Bishop’s and Professor Sir Peter Ratcliffe’s groups shed light on the developmental origins of inherited cancers with mutations in the HIF pathway.